Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Gilead Sciences Inc. (GILD)

70.1   -2.8 (-3.84%) 02-25 16:00
Open: 73.73 Pre. Close: 72.9
High: 73.8465 Low: 69.02
Volume: 39,199,212 Market Cap: 88687M
Gilead Sciences Inc is a biopharmaceutical company that discovers, develops and commercializes new medicines in areas of unmet medical need. Its products target a number of areas, such as HIV, liver diseases, cardiovascular and other diseases.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 73.936 - 74.326 74.326 - 74.657
Low: 68.137 - 68.559 68.559 - 68.919
Close: 69.401 - 70.123 70.123 - 70.738

Technical analysis

as of: 2020-02-25 4:29:58 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 87.04     One year: 101.66
Support: Support1: 66.92    Support2: 62.23
Resistance: Resistance1: 74.52    Resistance2: 87.04
Pivot: 68.16
Moving Average: MA(5): 69.41     MA(20): 67.24
MA(100): 65.43     MA(250): 65.41
MACD: MACD(12,26): 1.27     Signal(9): 0.87
Stochastic oscillator: %K(14,3): 74.95     %D(3): 70.27
RSI: RSI(14): 59.75
52-week: High: 74.52  Low: 60.89  Change(%): 6.9
Average Vol(K): 3-Month: 1127172  10-Days: 1721351

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
GILD has closed below upper band by 21.3%. Bollinger Bands are 53.9% wider than normal. The large width of the bands suggest high volatility as compared to GILD's normal range. The bands have been in this wide range for 1 bars. This is a sign that the current trend might continue.

Headline News

US drug maker seeks patents
BEIJING: Gilead Sciences, the US biotech company behind the experimental drug remdesivir, has applied for eight patents surrounding the drug in China, with three of them approved and the other five still pending, an official said.

Gilead Sciences : First U.S. Testing Begins for Potential Coronavirus Treatment | MarketScreener
By Joseph Walker Researchers have begun the first study in the U.S. of an experimental drug aimed at treating the novel coronavirus, the National Institutes of Health said Tuesday. … | February 25, 2020

Financial Analysis

Growth NA
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability NA
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency NA
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  Nasdaq Global Select
Sector:  Healthcare
Industry:  Drug Manufacturers - Major
Shares Out. (M) 1270.00
Shares Float (M) 1260.00
% Held by Insiders 0.54
% Held by Institutions 83.87
Shares Short (K) 21300
Shares Short P. Month (K)

Stock Financials

EPS 4.220
Book Value (p.s.) 17.890
PEG Ratio 7.62
Profit Margin 23.99
Operating Margin 22.67
Return on Assets (ttm) 5.1
Return on Equity (ttm) 24.3
Qtrly Rev. Growth 1.4
Gross Profit (p.s.) 13.992
Sales Per Share
EBITDA (p.s.) 5.110
Qtrly Earnings Growth 89766.70
Operating Cash Flow (M)
Levered Free Cash Flow (M)

Stock Valuations

P/E 16.61
P/E Growth Ratio -0.04
P/BV 3.92
P/S 3.96

Dividends & Splits

Dividend 2.520
Dividend Yield 0.04
Dividend Pay Date 2020-03-29
Ex-Dividend Date 2020-03-11
Forward Dividend 2.720
Last Split Date 2013-01-27
Last Split Ratio 2
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.